Tokyo, Japan

Nobuhiko Kayagaki


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2000-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nobuhiko Kayagaki: Innovator in Monoclonal Antibody Technology

Introduction

Nobuhiko Kayagaki, a distinguished inventor based in Tokyo, Japan, has made significant contributions to the field of biotechnology. With a focus on monoclonal antibodies, he has developed innovative solutions that advance medical science.

Latest Patents

Nobuhiko Kayagaki holds two patents, with his latest inventions having a strong relevance in the medical field. One of his recent patents is titled "Monoclonal antibody reacting specifically with Fas ligand and production process thereof." This invention provides monoclonal antibodies that specifically react with the Fas ligand or its active fragments. It includes a production process for these antibodies, hybridomas that produce them, and methods for detecting the Fas ligand in solutions. Furthermore, it features a kit designed for the detection of Fas ligand, comprising multiple monoclonal antibodies against the Fas ligand.

Another significant patent focuses on "Antibodies to Fas-L for treatment of hepatitis." This patent highlights Kayagaki's innovative approach to developing therapeutic antibodies aimed at treating hepatitis.

Career Highlights

Throughout his career, Nobuhiko Kayagaki has been associated with prominent companies, including Sumitomo Electric Industries, Limited, where he honed his expertise in antibody technology. His work has not only contributed to the scientific community but has also had important implications for therapeutic advancements.

Collaborations

Kayagaki has collaborated with notable coworkers such as Hideo Yagita and Ko Okumura. These collaborations have helped amplify the impact of his inventions in the realm of biotechnology, enabling the development of cutting-edge solutions in healthcare.

Conclusion

Nobuhiko Kayagaki’s innovations in monoclonal antibody technology reflect his commitment to advancing medical science. With two patents to his name, his contributions play a crucial role in the development of targeted therapies and diagnostic tools, paving the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…